HC Wainwright Reaffirms “Neutral” Rating for Inovio Pharmaceuticals (NASDAQ:INO)
HC Wainwright reiterated their neutral rating on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research report report published on Monday, Benzinga reports. HC Wainwright currently has a $15.00 price target on the biopharmaceutical company’s stock. Several other research firms have also recently commented on INO. Stephens began coverage on shares of Inovio […]
More Stories
LGI Homes, Inc. (NASDAQ:LGIH) Given Consensus Rating of “Hold” by Analysts
Shares of LGI Homes, Inc. (NASDAQ:LGIH – Get Free Report) have received an average recommendation of “Hold” from the five...
Xponential Fitness, Inc. (NYSE:XPOF) Receives $18.25 Average PT from Brokerages
Shares of Xponential Fitness, Inc. (NYSE:XPOF – Get Free Report) have been given an average recommendation of “Moderate Buy” by...
Getty Realty (NYSE:GTY) Price Target Raised to $33.00 at JPMorgan Chase & Co.
Getty Realty (NYSE:GTY – Get Free Report) had its price target increased by stock analysts at JPMorgan Chase & Co....
General Mills (NYSE:GIS) Rating Reiterated by Royal Bank of Canada
General Mills (NYSE:GIS – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank...
Sun Communities (NYSE:SUI) Given New $154.00 Price Target at Wells Fargo & Company
Sun Communities (NYSE:SUI – Get Free Report) had its price target increased by equities research analysts at Wells Fargo &...
OUTFRONT Media (NYSE:OUT) Coverage Initiated at Wells Fargo & Company
Equities research analysts at Wells Fargo & Company assumed coverage on shares of OUTFRONT Media (NYSE:OUT – Get Free Report)...